neuroblastoma - Articles and news items

Immunotherapy shrinks tumours in neuroblastoma patients

Industry news / 3 June 2016 / Victoria White, Digital Content Producer

Neuroblastoma tumours shrank in 80% of young, high-risk patients enrolled in a Phase II clinical trial that included an experimental monoclonal antibody…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+